- Home
- SYF vs WAT Comparison
SYF vs WAT Comparison
Compare SYF & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYF
- WAT
- Stock Information
- Founded
- SYF 1932
- WAT 1958
- Country
- SYF United States
- WAT United States
- Employees
- SYF N/A
- WAT N/A
- Industry
- SYF Finance: Consumer Services
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- SYF Finance
- WAT Industrials
- Exchange
- SYF Nasdaq
- WAT Nasdaq
- Market Cap
- SYF 20.3B
- WAT 21.9B
- IPO Year
- SYF N/A
- WAT 1995
- Fundamental
- Price
- SYF $52.22
- WAT $363.05
- Analyst Decision
- SYF Buy
- WAT Buy
- Analyst Count
- SYF 21
- WAT 14
- Target Price
- SYF $65.25
- WAT $393.00
- AVG Volume (30 Days)
- SYF 5.2M
- WAT 492.7K
- Earning Date
- SYF 04-23-2025
- WAT 05-06-2025
- Dividend Yield
- SYF 1.85%
- WAT N/A
- EPS Growth
- SYF 64.74
- WAT N/A
- EPS
- SYF 8.55
- WAT 10.71
- Revenue
- SYF $9,392,000,000.00
- WAT $2,958,387,000.00
- Revenue This Year
- SYF $102.56
- WAT $4.99
- Revenue Next Year
- SYF $6.13
- WAT $6.12
- P/E Ratio
- SYF $6.33
- WAT $34.65
- Revenue Growth
- SYF 22.58
- WAT 0.07
- 52 Week Low
- SYF $39.67
- WAT $279.24
- 52 Week High
- SYF $70.93
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- SYF 37.51
- WAT 45.25
- Support Level
- SYF $52.50
- WAT $363.51
- Resistance Level
- SYF $55.25
- WAT $377.52
- Average True Range (ATR)
- SYF 1.60
- WAT 10.78
- MACD
- SYF 0.48
- WAT 0.05
- Stochastic Oscillator
- SYF 38.17
- WAT 39.73
About SYF Synchrony Financial
Synchrony Financial, originally a spinoff of GE Capital's retail financing business, is the largest provider of private-label credit cards in the United States by both outstanding receivables and purchasing volume. Synchrony partners with other firms to market its credit products in their physical stores as well as on their websites and mobile applications. Synchrony operates through three segments: retail card (private-label and co-branded general-purpose credit cards), payment solutions (promotional financing for large ticket purchases), and CareCredit (financing for elective healthcare procedures).
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.